What will it take to develop new drugs for Lyme disease?
Dr. Raphael Stricker, a San Francisco internist and hematologist, is an internationally recognized leader in tick-borne disease diagnosis and treatment.
He is also a board member of LymeDisease.org.
Dr. Stricker recently delivered a recorded overview of tick-borne diseases to the European Society of Medicine Congress 2021. The title of his talk was “Lyme Disease: The New Pharma Frontier.”
As he notes in his introduction, “Over the past year, there have been at least four novel antiviral drugs for Covid-19 that have been developed. It’s disappointing that we haven’t seen the same kind of drug development for Lyme disease over the years. [In this presentation], I’d like to focus on that type of drug development.”
Click below to view his talk.